Insider · CIK 0001671111
Webb Carol
Reports to the SEC for 2 companies · CRANFORD, NJ
Transactions
20
Companies
2
Filings
18
CIK
0001671111
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-09-19 | CTORCITIUS ONCOLOGY, INC.A Award | — |
| 2025-09-19 | CTORCITIUS ONCOLOGY, INC.A Award | — |
| 2025-09-19 | CTORCITIUS ONCOLOGY, INC.A Award | — |
| 2024-12-12 | CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-11-07 | CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award | — |
| 2024-08-12 | CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-03-04 | CTXRCitius Pharmaceuticals, Inc.M Exercise/Conversion | +$181.065 |
| 2024-03-04 | CTXRCitius Pharmaceuticals, Inc.F Tax Payment | −$180.776 |
| 2024-03-04 | CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)M Exercise/Conversion | — |
| 2023-10-10 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2022-10-04 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2021-10-11 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2021-07-22 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2021-02-16 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2020-10-06 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2020-07-07 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2019-10-08 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2018-09-04 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2017-09-15 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | — |
| 2016-06-23 | CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award | +$160K |
Recent filings
- 4/AWebb Carol0001213900-25-124537SEC(opens sec.gov)
- 4/AWebb Carol0001213900-25-116681SEC(opens sec.gov)
- 4Webb Carol0001213900-25-090613SEC(opens sec.gov)
- 4Webb Carol0001213900-24-109300SEC(opens sec.gov)
- 4Webb Carol0001213900-24-096895SEC(opens sec.gov)
- 4Webb Carol0001213900-24-074505SEC(opens sec.gov)
- 4Webb Carol0001213900-24-069244SEC(opens sec.gov)
- 4Webb Carol0001013762-23-003535SEC(opens sec.gov)
- 4Webb Carol0001213900-22-062475SEC(opens sec.gov)
- 4Webb Carol0001213900-21-052674SEC(opens sec.gov)
- 4Webb Carol0001213900-21-038690SEC(opens sec.gov)
- 4Webb Carol0001213900-21-010316SEC(opens sec.gov)
- 4Webb Carol0001213900-20-030788SEC(opens sec.gov)
- 4Webb Carol0001213900-20-017089SEC(opens sec.gov)
- 4Webb Carol0001213900-19-020126SEC(opens sec.gov)
- 4Webb Carol0001213900-18-012204SEC(opens sec.gov)
- 4Webb Carol0001477932-17-004609SEC(opens sec.gov)
- 4Citius Pharmaceuticals, Inc.0001477932-16-011033SEC(opens sec.gov)
Companies
Address
C/O CITIUS ONCOLOGY, INC. 11 COMMERCE DRIVE, 1ST FLOOR
CRANFORD, NJ, 07016